{
  "user": "test_user_3_31m",
  "processed_at": "2026-01-07T22:39:59.194815",
  "documents": [
    {
      "filename": " (1).pdf",
      "file_size": 1410033,
      "text_length": 25605,
      "extracted_text": "PROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nREF. BY : SELF\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN\nTEST ASKED : HbA1c,HEMOGRAM ROAD ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI\nDISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nHbA1c - (HPLC)\nH.P.L.C 4.9 %\nBio. Ref. Interval. :\nBio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics\nBelow 5.7% : Normal Below 6.5% : Good Control\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\n>8% : Poor Control\nMethod : Fully Automated H.P.L.C method\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 94 mg/dL\nBio. Ref. Interval. :\n90 - 120 mg/dl : Good Control\n121 - 150 mg/dl : Fair Control\n151 - 180 mg/dl : Unsatisfactory Control\n> 180 mg/dl : Poor Control\nMethod : Derived from HBA1c values\nPlease correlate with clinical conditions.\nSample Collected on (SCT)...",
      "full_text": "PROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nREF. BY : SELF\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN\nTEST ASKED : HbA1c,HEMOGRAM ROAD ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI\nDISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nHbA1c - (HPLC)\nH.P.L.C 4.9 %\nBio. Ref. Interval. :\nBio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics\nBelow 5.7% : Normal Below 6.5% : Good Control\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\n>8% : Poor Control\nMethod : Fully Automated H.P.L.C method\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 94 mg/dL\nBio. Ref. Interval. :\n90 - 120 mg/dl : Good Control\n121 - 150 mg/dl : Fair Control\n151 - 180 mg/dl : Unsatisfactory Control\n> 180 mg/dl : Poor Control\nMethod : Derived from HBA1c values\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:16\nReport Released on (RRT) :07 Dec 2023 15:54\nSample Type :EDTA\nLabcode :[PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode :BL990342\nPage : 1 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nREF. BY : SELF A S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN\nTEST ASKED : HbA1c,HEMOGRAM\nROAD ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI\nPATIENTID : HK21184438 DISTRICT - 635109\nTEST NAME VALUE UNITS Bio. Ref. Interval.\nTOTAL LEUCOCYTES COUNT (WBC) 7.64 X 10³ / µL 4.0 - 10.0\nNEUTROPHILS 47.8 % 40-80\nLYMPHOCYTE 37.4 % 20-40\nMONOCYTES 6 % 2-10\nEOSINOPHILS 8.5 % 1-6\nBASOPHILS 0.5 % 0-2\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\nNEUTROPHILS - ABSOLUTE COUNT 3.63 X 10³ / µL 2.0-7.0\nLYMPHOCYTES - ABSOLUTE COUNT 2.86 X 10³ / µL 1.0-3.0\nMONOCYTES - ABSOLUTE COUNT 0.46 X 10³ / µL 0.2 - 1.0\nBASOPHILS - ABSOLUTE COUNT 0.04 X 10³ / µL 0.02 - 0.1\nEOSINOPHILS - ABSOLUTE COUNT 0.65 X 10³ / µL 0.02 - 0.5\nIMMATURE GRANULOCYTES(IG) 0.04 X 10³ / µL 0-0.3\nTOTAL RBC 5.43 X 10^6/µL 4.5-5.5\nNUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5\nNUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0\nHEMOGLOBIN 16.6 g/dL 13.0-17.0\nHEMATOCRIT(PCV) 49.3 % 40.0-50.0\nMEAN CORPUSCULAR VOLUME(MCV) 90.8 fL 83.0-101.0\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 30.6 pq 27.0-32.0\nMEAN CORP.HEMO.CONC(MCHC) 33.7 g/dL 31.5-34.5\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 43 fL 39-46\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 13.1 % 11.6-14\nPLATELET DISTRIBUTION WIDTH(PDW) 10.4 fL 9.6-15.2\nMEAN PLATELET VOLUME(MPV) 9.5 fL 6.5-12\nPLATELET COUNT 182 X 10³ / µL 150-410\nPLATELET TO LARGE CELL RATIO(PLCR) 21.4 % 19.7-42.4\nPLATELETCRIT(PCT) 0.17 % 0.19-0.39\nRemarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.\nPlease Correlate with clinical conditions.\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method\n(using a semiconductor laser), and SLS- hemoglobin method)\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) :07 Dec 2023 15:16\nReport Released on (RRT) :07 Dec 2023 15:54\nSample Type : EDTA\nLabcode : [PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode : BL990342 Page : 2 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME :HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nREF. BY : SELF\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN ROAD\nTEST ASKED : COMPLETE URINE ANALYSIS ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI DISTRICT\n- 635109\nPATIENTID : HK21184438\nTEST NAME OBSERVATION UNITS Bio. Ref. Interval.\nComplete Urinogram\nPhysical Examination\nVOLUME 3 mL -\nCOLOUR PALE YELLOW - Pale Yellow\nAPPEARANCE CLEAR - Clear\nSPECIFIC GRAVITY 1.02 - 1.003-1.030\nPH 5.5 - 5-8\nChemical Examination\nURINARY PROTEIN ABSENT mg/dL Absent\nURINARY GLUCOSE ABSENT mg/dL Absent\nURINE KETONE ABSENT mg/dL Absent\nURINARY BILIRUBIN ABSENT mg/dL Absent\nUROBILINOGEN Normal mg/dL <=0.2\nBILE SALT ABSENT - Absent\nBILE PIGMENT ABSENT - Absent\nURINE BLOOD ABSENT - Absent\nNITRITE ABSENT - Absent\nLEUCOCYTE ESTERASE ABSENT - Absent\nMicroscopic Examination\nMUCUS PRESENT - Absent\nRED BLOOD CELLS ABSENT cells/HPF 0-5\nURINARY LEUCOCYTES (PUS CELLS) 1 cells/HPF 0-5\nEPITHELIAL CELLS 1 cells/HPF 0-5\nCASTS ABSENT - Absent\nCRYSTALS ABSENT - Absent\nBACTERIA ABSENT - Absent\nYEAST ABSENT - Absent\nPARASITE ABSENT - Absent\nMethod : Fully Automated Matrix AVE Urinalysis Dipstick Method, Microscopy\nSample Collected on (SCT) : 07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:10\nReport Released on (RRT) : 07 Dec 2023 15:59\nSample Type : URINE\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/TN052\nBarcode : BP467049 Page : 3 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nREF. BY : SELF A S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN ROAD\nTEST ASKED : BLOOD SUGAR (F) ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI DISTRICT -\n635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nFASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 80.19 mg/dL\nBio. Ref. Interval. :-\nAs per ADA Guideline: Fasting Plasma Glucose (FPG)\nNormal 70 to 100 mg/dl\nPrediabetes 100 mg/dl to 125 mg/dl\nDiabetes 126 mg/dl or higher\nNote :\nThe assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,\nicteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and\nreagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical\nfindings and other findings.\nPlease correlate with clinical conditions.\nMethod:- GOD-PAP METHOD\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:11\nReport Released on (RRT) : 07 Dec 2023 15:56\nSample Type FLUORIDE\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/TN052\nBarcode : BR877534 Page : 4 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nREF. BY : SELF\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ROAD ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI\nDISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\n25-OH VITAMIN D (TOTAL) C.L.I.A 13.39 ng/mL\nBio. Ref. Interval. :\nDEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml\nSUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml\nClinical Significance:\nVitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical\nfor building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic\nsyndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.\nSpecifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.\nKit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.\nMethod : FULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY\nVITAMIN B-12 C.L.I.A 262 pg/mL\nBio. Ref. Interval. :\nNormal : 211 - 911 pg/ml\nClinical significance :\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs\nand milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.\nVitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For\ndiagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and\nother findings.\nSpecifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml\nKit Validation reference:\nChen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby;\n1987:569–73.\nMethod : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) :07 Dec 2023 17:12\nSample Type :SERUM\nLabcode :[PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode :BR968294\nPage : 5 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nREF. BY : SELF A S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN ROAD\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI DISTRICT -\n635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 2.75 mg/L\nBio. Ref. Interval. :-\n< 1.00 - Low Risk\n1.00 - 3.00 - Average Risk\n>3.00 - 10.00 - High Risk\n> 10.00 - Possibly due to Non-Cardiac Inflammation\nDisclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as\ninfection , active arthritis or concurrent illness.\nClinical significance:\nHigh sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk\nfor future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP\ntests, ideally taken two weeks apart.\nKit Validation Reference:\n1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).\n2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.\nPlease correlate with clinical conditions.\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/TN052\nBarcode : BR968294 Page : 6 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nREF. BY : SELF A S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN ROAD\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI DISTRICT -\n635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nTESTOSTERONE C.L.I.A 559.03 ng/dL\nBio. Ref. Interval. :-\nAdult Male\n21 - 49 Yrs : 164.94 - 753.38 || 50 - 89 Yrs : 86.49 - 788.22\nAdult Female\nPre-Menopause : 12.09 - 59.46 || Post-Menopause: < 7.00 - 48.93\nBoys\n2-10 Years : < 7.00 - 25.91\n11 Years : < 7.00 - 341.53\n12 Years : < 7.00 - 562.59\n13 Years : 9.34 - 562.93\n14 Years : 23.28 - 742.46\n15 Years : 144.15 - 841.44\n16-21 Years : 118.22 - 948.56\nGirls\n2-10 Years : < 7.00 - 108.30\n11-15 Years : < 7.00 - 48.40\n16-21 Years : 17.55 - 50.41\nClinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.\nMajor causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\nHypopituitarism some types of liver and kidney diseases and critical illness.\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\nKit Validation Reference: Kicklighter EJ, Norman RJ. The gonads. In: Kaplan LA, Pesce AJ, eds. Clinical Chemistry: Theory, Analysis,\nCorrelation. 2nd ed. St. Louis: CV Mosby; 1989:657–662.\nPlease correlate with clinical conditions.\nMethod:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/TN052\nBarcode : BR968294 Page : 7 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nREF. BY : SELF\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ROAD ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI\nDISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nIRON PHOTOMETRY 148.12 µg/dL\nBio. Ref. Interval. :\nMale : 65 - 175\nFemale : 50 - 170\nMethod : FERROZINE METHOD WITHOUT DEPROTEINIZATION\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 317.82 µg/dL\nBio. Ref. Interval. :\nMale: 225 - 535 µg/dl Female: 215 - 535 µg/dl\nMethod : SPECTROPHOTOMETRIC ASSAY\n% TRANSFERRIN SATURATION CALCULATED 46.6 %\nBio. Ref. Interval. :\n13 - 45\nMethod : DERIVED FROM IRON AND TIBC VALUES\nUNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 169.7 µg/dL\nBio. Ref. Interval. :\n162 - 368\nMethod : SPECTROPHOTOMETRIC ASSAY\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) :07 Dec 2023 17:12\nSample Type :SERUM\nLabcode :[PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode :BR968294\nPage : 8 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST FLOOR,SP\nREF. BY : SELF\nCOMPLEX,DENKANIKOTTAI MAIN ROAD ,SHANTHI NAGAR\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,HOSUR KRISHNAGIRI DISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nTOTAL CHOLESTEROL PHOTOMETRY 202 mg/dL < 200\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 50 mg/dL 40-60\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 140 mg/dL < 100\nTRIGLYCERIDES PHOTOMETRY 70 mg/dL < 150\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4 Ratio 3 - 5\nTRIG / HDL RATIO CALCULATED 1.4 Ratio < 3.12\nLDL / HDL RATIO CALCULATED 2.8 Ratio 1.5-3.5\nHDL / LDL RATIO CALCULATED 0.36 Ratio > 0.40\nNON-HDL CHOLESTEROL CALCULATED 151.8 mg/dL < 160\nVLDL CHOLESTEROL CALCULATED 14.06 mg/dL 5 - 40\nPlease correlate with clinical conditions.\nMethod :\nCHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE\nHCHO - DIRECT ENZYMATIC COLORIMETRIC\nLDL - DIRECT MEASURE\nTRIG - ENZYMATIC, END POINT\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\nTRI/H - DERIVED FROM TRIG AND HDL VALUES\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\nHD/LD - DERIVED FROM HDL AND LDL VALUES.\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\nDESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\nBORDERLINE HIGH\nHIGH >240 130-159 HIGH 200-499\nHIGH 160-189 VERY HIGH >500\nVERY HIGH >190\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\nSample Collected on (SCT) : 07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type : SERUM\nLabcode : [PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode : BR968294\nPage : 9 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST FLOOR,SP\nREF. BY : SELF\nCOMPLEX,DENKANIKOTTAI MAIN ROAD ,SHANTHI NAGAR\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,HOSUR KRISHNAGIRI DISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nALKALINE PHOSPHATASE PHOTOMETRY 54.9 U/L 45-129\nBILIRUBIN - TOTAL PHOTOMETRY 0.56 mg/dL 0.3-1.2\nBILIRUBIN -DIRECT PHOTOMETRY 0.12 mg/dL < 0.3\nBILIRUBIN (INDIRECT) CALCULATED 0.44 mg/dL 0-0.9\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 33.3 U/L < 55\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 25.45 U/L < 35\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.83 U/L < 45\nSGOT / SGPT RATIO CALCULATED 1.17 Ratio < 2\nPROTEIN - TOTAL PHOTOMETRY 7.4 gm/dL 5.7-8.2\nALBUMIN - SERUM PHOTOMETRY 4.71 gm/dL 3.2-4.8\nSERUM GLOBULIN CALCULATED 2.69 gm/dL 2.5-3.4\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.75 Ratio 0.9 - 2\nPlease correlate with clinical conditions.\nMethod :\nALKP - MODIFIED IFCC METHOD\nBILT - VANADATE OXIDATION\nBILD - VANADATE OXIDATION\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\nGGT - MODIFIED IFCC METHOD\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\nOT/PT - DERIVED FROM SGOT AND SGPT VALUES.\nPROT - BIURET METHOD\nSALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\nSample Collected on (SCT) : 07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type : SERUM\nLabcode : [PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode : BR968294\nPage : 10 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST FLOOR,SP\nREF. BY : SELF\nCOMPLEX,DENKANIKOTTAI MAIN ROAD ,SHANTHI NAGAR\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,HOSUR KRISHNAGIRI DISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 10.13 mg/dL 7.94 - 20.07\nCREATININE - SERUM PHOTOMETRY 0.85 mg/dL 0.72-1.18\nBUN / SR.CREATININE RATIO CALCULATED 11.92 Ratio 9:1-23:1\nUREA (CALCULATED) CALCULATED 21.68 mg/dL Adult : 17-43\nUREA / SR.CREATININE RATIO CALCULATED 25.5 Ratio < 52\nCALCIUM PHOTOMETRY 10.02 mg/dL 8.8-10.6\nURIC ACID PHOTOMETRY 4.79 mg/dL 4.2 - 7.3\nSODIUM I.S.E 140 mmol/L 136 - 145\nCHLORIDE I.S.E 104 mmol/L 98 - 107\nPlease correlate with clinical conditions.\nMethod :\nBUN - KINETIC UV ASSAY.\nSCRE - CREATININE ENZYMATIC METHOD\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\nUREAC - DERIVED FROM BUN VALUE.\nUR/CR - DERIVED FROM UREA AND SR.CREATININE VALUES.\nCALC - ARSENAZO III METHOD, END POINT.\nURIC - URICASE / PEROXIDASE METHOD\nSOD - ION SELECTIVE ELECTRODE\nCHL - ION SELECTIVE ELECTRODE\nSample Collected on (SCT) : 07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type : SERUM\nLabcode : [PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode : BR968294\nPage : 11 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nA S DIAGNOSTIC CENTRE, NO 18/35,FIRST FLOOR,SP\nREF. BY : SELF\nCOMPLEX,DENKANIKOTTAI MAIN ROAD ,SHANTHI NAGAR\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,HOSUR KRISHNAGIRI DISTRICT - 635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nTOTAL TRIIODOTHYRONINE (T3) C.M.I.A 108 ng/dL 58-159\nTOTAL THYROXINE (T4) C.M.I.A 8.41 µg/dL 4.87-11.72\nTSH - ULTRASENSITIVE C.M.I.A 3.098 µIU/mL 0.35-4.94\nThe Biological Reference Ranges is specific to the age group. Kindly correlate clinically.\nMethod :\nT3,T4,USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay\nDisclaimer :Results should always be interpreted using the reference range provided by the laboratory that\nperformed the test. Different laboratories do tests using different technologies, methods and using different\nreagents which may cause difference. In reference ranges and hence it is recommended to interpret result with\nassay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended\nto get tested every time at the same Laboratory.\nSample Collected on (SCT) : 07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type : SERUM\nLabcode\n: [PHONE]/TN052 Dr Ishant Anand MD(Path)\nBarcode : BR968294 Page : 12 of 15\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : HARISH [REDACTED] (29Y/M) SAMPLE COLLECTED AT :\nREF. BY : SELF A S DIAGNOSTIC CENTRE, NO 18/35,FIRST\nFLOOR,SP COMPLEX,DENKANIKOTTAI MAIN ROAD\nTEST ASKED : AAROGYAM C PLUS PROFILE WITH UTSH ,SHANTHI NAGAR ,HOSUR KRISHNAGIRI DISTRICT -\n635109\nPATIENTID : HK21184438\nTEST NAME TECHNOLOGY VALUE UNITS\nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 118 mL/min/1.73 m2\nBio. Ref. Interval. :-\n> = 90 : Normal\n60 - 89 : Mild Decrease\n45 - 59 : Mild to Moderate Decrease\n30 - 44 : Moderate to Severe Decrease\n15 - 29 : Severe Decrease\nClinical Significance\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and\nmoderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely\nestimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value\nwhen serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in\nclinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to\ninterpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the\npercentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal\nmedicine will further improve the detection and management of patients with CKD.\nReference\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration\nrate. Ann Intern Med. 2009;150(9):604-12.\nPlease correlate with clinical conditions.\nMethod:- CKD-EPI Creatinine Equation\n~~ End of report ~~\nSample Collected on (SCT) :07 Dec 2023 08:25\nSample Received on (SRT) : 07 Dec 2023 15:14\nReport Released on (RRT) : 07 Dec 2023 17:12\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/TN052\nBarcode : BR968294 Page : 13 of 15\n\nCUSTOMER DETAILS\nAs declared in our data base\nName: HARISH [REDACTED] Age: 29Y Sex: M\nBarcodes/Sample_Type : BL990342 (EDTA),BP467049 (URINE),BR877534 (FLUORIDE),BR968294 (SERUM)\nLabcode : [PHONE],[PHONE],[PHONE],[PHONE]\nRef By : SELF\nSample_Type/Tests : EDTA:HBA , HEMOGRAM - 6 PART (DIFF)\nURINE:COMPLETE URINE ANALYSIS\nFLUORIDE:FBS\nSERUM:AAROGYAM C PLUS PROFILE WITH UTSH\nSample Collected At : A S DIAGNOSTIC CENTRE, NO 18/35,FIRST FLOOR,SP\nCOMPLEX,DENKANIKOTTAI MAIN ROAD ,SHANTHI NAGAR ,HOSUR\nKRISHNAGIRI DISTRICT - 635109\nSample Collected on (SCT) : 07 Dec 2023 08:25\nReport Released on (RRT) : 07 Dec 2023 17:12\nAmount Collected : Rs.1600/-(one thousand six hundred only)\nThyrocare,D-37/1,MIDC,Turbhe,Navi Mumbai - 400703. | Phone:022 - 6712 3400 |www.thyrocare.com | [EMAIL]\nPage : 14 of 15\n\nCONDITIONS OF REPORTING\nv The reported results are for information and interpretation of the referring doctor only.\nv It is presumed that the tests performed on the specimen belong to the patient; named or identified.\nv Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same\npatient.\nv Should the results indicate an unexpected abnormality, the same should be reconfirmed.\nv Only such medical professionals who understand reporting units, reference ranges and limitations of technologies\nshould interpret results.\nv This report is not valid for medico-legal purpose.\nv Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that\nmay be incurred by any person as a result of presuming the meaning or contents of the report.\nv Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc\nv For clinical support please contact @[PHONE],[PHONE],[PHONE] between 10:00 to 18:00\nEXPLANATIONS\nv Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\nas \"Clients\".\nv Name - The name is as declared by the client and recored by the personnel who collected the specimen.\nv Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\nv Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\nv Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\nthe barcode (irrespective of the name).\nv SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\nthe client.\nv SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\nv SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\nv RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\nv Reference Range - Means the range of values in which 95% of the normal population would fall.\nSUGGESTIONS\nv Values out of reference range requires reconfirmation before starting any medical treatment.\nv Retesting is needed if you suspect any quality shortcomings.\nv Testing or retesting should be done in accredited laboratories.\nv For suggestions, complaints or feedback, write to us at [EMAIL] or call us on\n022-3090 0000 / 6712 3400\nv SMS:<Labcode No.> to [PHONE]\n*As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)\nPage : 15 of 15",
      "biomarkers": {
        "hemoglobin": "16.6"
      },
      "has_content": true
    },
    {
      "filename": " (2) (1).pdf",
      "file_size": 2731855,
      "text_length": 40232,
      "extracted_text": "Name : [REDACTED](30Y/M)\nDate : 06 Mar 2025\nTest Asked : Aarogyam Male With Utsh, Fbs + 1 Others\nReport Status: Complete Report\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF\nPEARL OF PARADISE LOCATION SHARED 560068\nTEST ASKED : AAROGYAM MALE WITH UTSH,FBS,ROUTINE URINE [PHONE]\nANALYSIS\nReport Availability Summary\nNote: Please refer to the table below for status of your tests.\n19 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab\nTEST DETAILS REPORT STATUS\nFASTING BLOOD SUGAR(GLUCOSE) Ready\nAAROGYAM MALE WITH UTSH Ready\nFOLATE Ready\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready\nLIPASE Ready\nLipoprotein (a) [Lp(a)] Ready\nPROSTATE SPECIFIC ANTIGEN (PSA) Ready\nTESTOSTERONE Ready\nHBA PROFILE Ready\nHEMOGRAM - 6 PART (DIFF) Ready\nLIVER FUNCTION TESTS Ready\nSERUM ELECTROLYTES Ready\nELEMENTS 22 (TOXIC AND NUTRIENTS) Ready\nIRON DEFICIENCY PROFILE Ready\nLIPID PROFILE Ready\nT3-T4-USTSH...",
      "full_text": "Name : [REDACTED](30Y/M)\nDate : 06 Mar 2025\nTest Asked : Aarogyam Male With Utsh, Fbs + 1 Others\nReport Status: Complete Report\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF\nPEARL OF PARADISE LOCATION SHARED 560068\nTEST ASKED : AAROGYAM MALE WITH UTSH,FBS,ROUTINE URINE [PHONE]\nANALYSIS\nReport Availability Summary\nNote: Please refer to the table below for status of your tests.\n19 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab\nTEST DETAILS REPORT STATUS\nFASTING BLOOD SUGAR(GLUCOSE) Ready\nAAROGYAM MALE WITH UTSH Ready\nFOLATE Ready\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready\nLIPASE Ready\nLipoprotein (a) [Lp(a)] Ready\nPROSTATE SPECIFIC ANTIGEN (PSA) Ready\nTESTOSTERONE Ready\nHBA PROFILE Ready\nHEMOGRAM - 6 PART (DIFF) Ready\nLIVER FUNCTION TESTS Ready\nSERUM ELECTROLYTES Ready\nELEMENTS 22 (TOXIC AND NUTRIENTS) Ready\nIRON DEFICIENCY PROFILE Ready\nLIPID PROFILE Ready\nT3-T4-USTSH Ready\nVITAMIN D TOTAL AND B12 COMBO Ready\nAPOLIPROTEIN RATIO Ready\nAMYLASE Ready\nROUTINE URINE ANALYSIS Ready\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\nTEST ASKED : AAROGYAM MALE WITH UTSH,FBS,ROUTINE URINE [PHONE]\nANALYSIS\nSummary Report\nTests outside reference range\nTEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.\nCARDIAC RISK MARKERS\nLIPOPROTEIN (A) [LP(A)] 53.39 mg/dL < 30\nCOMPLETE HEMOGRAM\nMONOCYTES - ABSOLUTE COUNT 0.16 X 10³ / µL 0.2 - 1.0\nHORMONE\nTESTOSTERONE 884.25 ng/dL 164.94 - 753.38\nLIPID\nHDL / LDL RATIO 0.38 Ratio > 0.40\nLDL CHOLESTEROL - DIRECT 131 mg/dL < 100\nTOTAL CHOLESTEROL 201 mg/dL < 200\nLIVER\nALANINE TRANSAMINASE (SGPT) 58.9 U/L < 45\nASPARTATE AMINOTRANSFERASE (SGOT ) 40.5 U/L < 35\nGAMMA GLUTAMYL TRANSFERASE (GGT) 71.1 U/L < 55\nTOXIC ELEMENTS\nBERYLLIUM 0.04 µg/L 0.10 - 0.80\nVITAMIN\n25-OH VITAMIN D (TOTAL) 25.03 ng/mL 30-100\nVITAMINS\nFOLATE 4 ng/mL > 5.38\nDisclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,\nparameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME :[REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.\nComplete Urinogram\nPhysical Examination\nVOLUME Visual Determination 3 mL -\nCOLOUR Visual Determination PALE YELLOW - Pale Yellow\nAPPEARANCE Visual Determination CLEAR - Clear\nSPECIFIC GRAVITY pKa change 1.015 - 1.003-1.030\nPH pH indicator 5.5 - 5-8\nChemical Examination\nURINARY PROTEIN PEI ABSENT mg/dL Absent\nURINARY GLUCOSE GOD-POD ABSENT mg/dL Absent\nURINE KETONE Nitroprusside ABSENT mg/dL Absent\nURINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent\nUROBILINOGEN Diazo coupling Normal mg/dL <=0.2\nURINE BLOOD Peroxidase reaction ABSENT - Absent\nNITRITE Diazo coupling ABSENT - Absent\nLEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent\nMicroscopic Examination\nURINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5\n(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)\nSample Collected on (SCT) : 06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:22\nReport Released on (RRT) : 06 Mar 2025 11:30\nSample Type : URINE\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DK593075 Page : 1 of 22\nScan QR code to verify authenticity of reported results; active for 30 days from release time.\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\n25-OH VITAMIN D (TOTAL) C.L.I.A 25.03 ng/mL\nBio. Ref. Interval. :\nDEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml\nSUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml\nClinical Significance:\nVitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building\nbone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome. Increase in\nvitamin D total levels indicate Vitamin D intoxication.\nSpecifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.\nKit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.\nMethod : Fully Automated Chemi Luminescent Immuno Assay\nVITAMIN B-12 C.L.I.A 242 pg/mL\nBio. Ref. Interval. :\nNormal : 211 - 911 pg/ml\nClinical significance :\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It\nis critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find\nout neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be\nassessed in conjunction with the patients medical history, clinical examination and other findings.\nSpecifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml\nKit Validation reference:\nChen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby; 1987:569–73.\nMethod : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) :06 Mar 2025 16:07\nSample Type :SERUM\nLabcode :[PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode :DF029453\nPage : 2 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETR 137 mg/dL\nY\nBio. Ref. Interval. :\nMale : 86 - 152\nFemale : 94 - 162\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETR 100 mg/dL\nY\nBio. Ref. Interval. :\nMale : 56 - 145\nFemale : 53 - 138\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER\nAPO B / APO A1 RATIO (APO B/A1) CALCULATED 0.7 Ratio\nBio. Ref. Interval. :\nMale : 0.40 - 1.26\nFemale : 0.38 - 1.14\nClinical Significance :\n• Apolipoprotein B is a more potent and independent predictor of Coronary artery disease (CAD) than LDL Cholesterol.\n• Apolipoprotein A1 is one of the apoproteins of HDL and is inversely related to risk of CAD.\n• The Apolipoprotein studies help in monitoring risk of restenosis in patients with myocardial infarction, Coronary bypass surgery etc.\n• An increased ratio of Apo B to A1 beyond the defined normal range is indicative of CAD risk.\n• All results have to be interpreted in Conjunction with clinical history and other findings.\nMethod : Derived from serum Apo A1 and Apo B values\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) :06 Mar 2025 16:07\nSample Type :SERUM\nLabcode :[PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode :DF029453\nPage : 3 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nFOLATE C.L.I.A 4 ng/mL\nBio. Ref. Interval. :-\n> 5.38 ng/ml\nClinical Significance: Low folate intake, malabsorption as a result of gastrointestinal diseases, pregnancy, and drugs such as\nphenytoin are causes of folate deficiency.3 Folate deficiency is also associated with chronic alcoholism. Serum folate measurement\nprovides an early index of folate status.\nSpecifications: Precision: Intra assay (%CV): 7.93, Inter assay (%CV): 7.19, Sensitivity: 0.35 ng/mL.\nKit Validation References: Steinkamp RC. Vitamin B12 and folic acid: clinical and pathophysiological considerations. In: Brewster\nMA, Naito HK, eds. Nutritional Elements and Clinical Biochemistry. New York: Plenum Publishing Corp.; 1980:169–240\nPlease correlate with clinical conditions.\nMethod:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 4 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 1.46 mg/L\nBio. Ref. Interval. :-\n< 1.00 - Low Risk\n1.00 - 3.00 - Average Risk\n>3.00 - 10.00 - High Risk\n> 10.00 - Possibly due to Non-Cardiac Inflammation\nDisclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as\ninfection , active arthritis or concurrent illness.\nClinical significance:\nHigh sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk\nfor future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP\ntests, ideally taken two weeks apart.\nKit Validation Reference:\n1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).\n2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.\nPlease correlate with clinical conditions.\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 5 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 53.39 mg/dL\nBio. Ref. Interval. :-\nAdults : < 30.0 mg/dl\nClinical Significance:\nDetermination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The\nlevels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for\ndiagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and\nother findings.\nSpecifications:\nPrecision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %\nKit Validation Reference:\nTietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444\nPlease correlate with clinical conditions.\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 6 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nTESTOSTERONE C.L.I.A 884.25 ng/dL\nBio. Ref. Interval. :-\nAdult Male\n21 - 49 Yrs : 164.94 - 753.38 || 50 - 89 Yrs : 86.49 - 788.22\nAdult Female\nPre-Menopause : 12.09 - 59.46 || Post-Menopause: < 7.00 - 48.93\nBoys\n2-10 Years : < 7.00 - 25.91\n11 Years : < 7.00 - 341.53\n12 Years : < 7.00 - 562.59\n13 Years : 9.34 - 562.93\n14 Years : 23.28 - 742.46\n15 Years : 144.15 - 841.44\n16-21 Years : 118.22 - 948.56\nGirls\n2-10 Years : < 7.00 - 108.30\n11-15 Years : < 7.00 - 48.40\n16-21 Years : 17.55 - 50.41\nClinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.\nMajor causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\nHypopituitarism some types of liver and kidney diseases and critical illness.\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\nKit Validation Reference: Kicklighter EJ, Norman RJ. The gonads. In: Kaplan LA, Pesce AJ, eds. Clinical Chemistry: Theory, Analysis,\nCorrelation. 2nd ed. St. Louis: CV Mosby; 1989:657–662.\nPlease correlate with clinical conditions.\nMethod:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 7 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nPROSTATE SPECIFIC ANTIGEN (PSA) C.L.I.A 0.34 ng/mL\nBio. Ref. Interval. :-\nNormal : < 4.00 ng/ml\nBorder line : 4.01 to 10.00 ng/ml\nClinical Significance:\nElevated levels of PSA are associated with prostate cancer, but may also be seen with prostatitis (Inflammation of the prostate)\nand benign prostatic hyperplasia (BPH). PSA test done along with free PSA provides additional information. Studies have\nsuggested that the percentage of free PSA in total PSA is lower in patients with prostate cancer than those with benign prostate\nhyperplasia.\nSpecification:\nPrecision: Intra assay (%CV): 4.38%, Inter assay (%CV): 4.67%; Sensitivity: 0.01 ng/ml\nKit validation references:\nWang MC, Valenzuala LA, Murphy GP, and Chu TM. Purification of a human prostate-specific antigen. Invest. Urol. 1979; 17: 159\nPlease correlate with clinical conditions.\nMethod:- TWO SITE SANDWICH IMMUNOASSAY\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 8 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nAMYLASE PHOTOMETRY 81.06 U/L\nBio. Ref. Interval. :-\nAdults : 28-100 U/L\nInterpretation:\nLipemic Sera (Hypertriglyceridemia) may contain inhibitors, Which falsely depress results. About 20% of patients with Acute\nPancreatitis have abnormal lipids. Normal serum amylase may occur in Pancreatitis, Especially relapsing and chronic pancreatitis.\nModerate increases may be reported in normal pregnancy.\nClinical Significance:\nCauses of high Serum Amylase include Acute Pancreatitis, Pancreatic Pseudocyst, Pancreatic Ascites, Pancreatic Abscess,\nNeoplasm in or adjacent to Pancreas, Trauma to Pancreas, and common Duct Stones. Nonpancreatic Causes include inflammatory\nsalivary lesions (Eg, Mumps), Perforated Peptic Ulcer, Intestinal Obstruction, Biliary Tract Disease, Peritonitis, Acute Appendicitis,\nDiabetic Ketoacidosis, and Extrapancreatic Carcinomas. Amylase levels more than 25-fold the upper limit of normal are often found\nwhen metastatic tumors produce Ectopic Amylase.\nSpecifications:\nPrecision: Intra assay (%CV): 2.82, Inter assay (%CV): 2.49, Sensitivity: 10.9 U/L.\nKit Validation References:\nRauscher, E., et coll., Fresenius Z. Analyt. Chem. 324 (1986) 304-305.\nPlease correlate with clinical conditions.\nMethod:- ENZYMATIC COLORIMETRIC TEST\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 9 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nIRON PHOTOMETRY 120.41 µg/dL\nBio. Ref. Interval. :\nMale : 65 - 175\nFemale : 50 - 170\nMethod : Ferrozine method without deproteinization\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 288.5 µg/dL\nBio. Ref. Interval. :\nMale: 225 - 535 µg/dl Female: 215 - 535 µg/dl\nMethod : Spectrophotometric Assay\n% TRANSFERRIN SATURATION CALCULATED 41.74 %\nBio. Ref. Interval. :\n13 - 45\nMethod : Derived from IRON and TIBC values\nUNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 168.09 µg/dL\nBio. Ref. Interval. :\n162 - 368\nMethod : SPECTROPHOTOMETRIC ASSAY\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) :06 Mar 2025 16:07\nSample Type :SERUM\nLabcode :[PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode :DF029453\nPage : 10 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nLIPASE PHOTOMETRY 39.24 U/L\nBio. Ref. Interval. :-\nAdults : 5.6 - 51.3 U/L\nInterpretation:\nFor diagnostic purposes, the results should always be assessed in conjunction with the patient’s medical history, clinical\nexamination and other findings like serum amylase. Serum Lipase is usually normal in patients with elevated serum amylase,\nhaving peptic ulcer, salivary adenitis, inflammatory bowel disease, intestinal obstruction, and macroamylasemia. Lipemic sera may\ninterfere with results.\nClinical Significance:\nHigh serum Lipase is a specific marker for pancreatitis; after acute pancreatitis the Lipase activity increases within 4-8 hours,\nreaches a peak after 24 hours and decreases after 8 to 14 days. However, there is no correlation between the Lipase activity\ndetermined in serum and the extent of damage to the pancreas.\nSpecifications:\nPrecision: Intra assay (%CV): 3.35, Inter assay (%CV): 2.46, Sensitivity: 3.5 U/L.\nKit Validation References:\nTietz Nw Et Al. Lipase In Serum - The Elusive Enzyme: An Overview. Clin Chem 1993; 39:746-756.\nPlease correlate with clinical conditions.\nMethod:- ENZYMATIC COLORIMETRIC ASSAY\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 11 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nTOTAL CHOLESTEROL PHOTOMETRY 201 mg/dL < 200\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 50 mg/dL 40-60\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 131 mg/dL < 100\nTRIGLYCERIDES PHOTOMETRY 80 mg/dL < 150\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4 Ratio 3 - 5\nTRIG / HDL RATIO CALCULATED 1.61 Ratio < 3.12\nLDL / HDL RATIO CALCULATED 2.6 Ratio 1.5-3.5\nHDL / LDL RATIO CALCULATED 0.38 Ratio > 0.40\nNON-HDL CHOLESTEROL CALCULATED 150.6 mg/dL < 160\nVLDL CHOLESTEROL CALCULATED 16.08 mg/dL 5 - 40\nPlease correlate with clinical conditions.\nMethod :\nCHOL - Cholesterol Oxidase, Esterase, Peroxidase\nHCHO - Direct Enzymatic Colorimetric\nLDL - Direct Measure\nTRIG - Enzymatic, End Point\nTC/H - Derived from serum Cholesterol and Hdl values\nTRI/H - Derived from TRIG and HDL Values\nLDL/ - Derived from serum HDL and LDL Values\nHD/LD - Derived from HDL and LDL values.\nNHDL - Derived from serum Cholesterol and HDL values\nVLDL - Derived from serum Triglyceride values\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\nDESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\nBORDERLINE HIGH\nHIGH >240 130-159 HIGH 200-499\nHIGH 160-189 VERY HIGH >500\nVERY HIGH >190\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\nSample Collected on (SCT) : 06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type : SERUM\nLabcode : [PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode : DF029453\nPage : 12 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nALKALINE PHOSPHATASE PHOTOMETRY 50.2 U/L 45-129\nBILIRUBIN - TOTAL PHOTOMETRY 0.42 mg/dL 0.3-1.2\nBILIRUBIN -DIRECT PHOTOMETRY 0.07 mg/dL < 0.3\nBILIRUBIN (INDIRECT) CALCULATED 0.35 mg/dL 0-0.9\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 71.1 U/L < 55\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 40.5 U/L < 35\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 58.9 U/L < 45\nSGOT / SGPT RATIO CALCULATED 0.69 Ratio < 2\nPROTEIN - TOTAL PHOTOMETRY 6.81 gm/dL 5.7-8.2\nALBUMIN - SERUM PHOTOMETRY 4.29 gm/dL 3.2-4.8\nSERUM GLOBULIN CALCULATED 2.52 gm/dL 2.5-3.4\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.7 Ratio 0.9 - 2\nPlease correlate with clinical conditions.\nMethod :\nALKP - Modified IFCC method\nBILT - Vanadate Oxidation\nBILD - Vanadate Oxidation\nBILI - Derived from serum Total and Direct Bilirubin values\nGGT - Modified IFCC method\nSGOT - IFCC* Without Pyridoxal Phosphate Activation\nSGPT - IFCC* Without Pyridoxal Phosphate Activation\nOT/PT - Derived from SGOT and SGPT values.\nPROT - Biuret Method\nSALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\nA/GR - Derived from serum Albumin and Protein values\nSample Collected on (SCT) : 06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type : SERUM\nLabcode : [PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode : DF029453\nPage : 13 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159,\nBangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nSODIUM I.S.E - INDIRECT 141 mmol/L\nBio. Ref. Interval. :\nADULTS: 136-145 MMOL/L\nMethod : ION SELECTIVE ELECTRODE - INDIRECT\nPOTASSIUM I.S.E - INDIRECT 4.4 mmol/L\nBio. Ref. Interval. :\nADULTS: 3.5-5.1 MMOL/L\nClinical Significance :\nAn abnormal increase in potassium (hyperkalemia)can profoundly affect the nervous system and increase the chance of irregular heartbeats\n(arrhythmias), which ,when extreme ,can be fatal. The assay could be affected mildly and may result in anomalous values if serum samples have\nheterophilic antibodies, hemolyzed , icteric or lipemic. The concentration of Potassium in a given specimen may vary due to differences in assay\nmethods, calibration and reagent specificity.\nMethod : ION SELECTIVE ELECTRODE - INDIRECT\nCHLORIDE I.S.E - INDIRECT 107 mmol/L\nBio. Ref. Interval. :\nADULTS: 98-107 MMOL/L\nClinical Significance :\nAn increased level of blood chloride (called hyperchloremia) usually indicates dehydration, but can also occur with other problems that cause high\nblood sodium, such as Cushing syndrome or kidney disease. Hyperchloremia also occurs when too much base is lost from the body (producing\nmetabolic acidosis) or when a person hyperventilates (causing respiratory alkalosis). A decreased level of blood chloride (called hypochloremia)\noccurs with any disorder that causes low blood sodium. Hypochloremia also occurs with congestive heart failure, prolonged vomiting or gastric\nsuction, Addison disease, emphysema or other chronic lung diseases (causing respiratory acidosis), and with loss of acid from the body (called\nmetabolic alkalosis).\nMethod : ION SELECTIVE ELECTRODE - INDIRECT\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) :06 Mar 2025 16:07\nSample Type :SERUM\nLabcode :[PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode :DF029453\nPage : 14 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 12.64 mg/dL 7.94 - 20.07\nCREATININE - SERUM PHOTOMETRY 0.82 mg/dL 0.72-1.18\nBUN / SR.CREATININE RATIO CALCULATED 15.41 Ratio 9:1-23:1\nUREA (CALCULATED) CALCULATED 27.05 mg/dL Adult : 17-43\nUREA / SR.CREATININE RATIO CALCULATED 32.99 Ratio < 52\nCALCIUM PHOTOMETRY 9.91 mg/dL 8.8-10.6\nURIC ACID PHOTOMETRY 4.96 mg/dL 4.2 - 7.3\nPlease correlate with clinical conditions.\nMethod :\nBUN - Kinetic UV Assay.\nSCRE - Creatinine Enzymatic Method\nB/CR - Derived from serum Bun and Creatinine values\nUREAC - Derived from BUN Value.\nUR/CR - Derived from UREA and Sr.Creatinine values.\nCALC - Arsenazo III Method, End Point.\nURIC - Uricase / Peroxidase Method\nSample Collected on (SCT) : 06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type : SERUM\nLabcode : [PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode : DF029453\nPage : 15 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nTOTAL TRIIODOTHYRONINE (T3) C.M.I.A 93 ng/dL 58-159\nTOTAL THYROXINE (T4) C.M.I.A 6.97 µg/dL 4.87-11.72\nTSH - ULTRASENSITIVE C.M.I.A 1.821 µIU/mL 0.35-4.94\nThe Biological Reference Ranges is specific to the age group. Kindly correlate clinically.\nMethod :\nT3,T4,USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay\nDisclaimer :Results should always be interpreted using the reference range provided by the laboratory that\nperformed the test. Different laboratories do tests using different technologies, methods and using different\nreagents which may cause difference. In reference ranges and hence it is recommended to interpret result with\nassay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended\nto get tested every time at the same Laboratory.\nSample Collected on (SCT) : 06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type : SERUM\nLabcode\n: [PHONE]/PP004 Dr Ishant Anand MD(Path)\nBarcode : DF029453 Page : 16 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 121 mL/min/1.73 m2\nBio. Ref. Interval. :-\n> = 90 : Normal\n60 - 89 : Mild Decrease\n45 - 59 : Mild to Moderate Decrease\n30 - 44 : Moderate to Severe Decrease\n15 - 29 : Severe Decrease\nClinical Significance\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and\nmoderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely\nestimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value\nwhen serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in\nclinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to\ninterpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the\npercentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal\nmedicine will further improve the detection and management of patients with CKD.\nReference\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration\nrate. Ann Intern Med. 2009;150(9):604-12.\nPlease correlate with clinical conditions.\nMethod:- 2021 CKD EPI Creatinine Equation\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:21\nReport Released on (RRT) : 06 Mar 2025 16:07\nSample Type SERUM\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DF029453 Page : 17 of 22\n\nPROCESSED AT :\nThyrocare,\n5CA-711, 3rd Floor,\nHRBR 2nd Block,\nHennur, Bengaluru-560043\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.\nARSENIC ICP-MS 0.34 µg/L < 5\nCADMIUM ICP-MS 0.65 µg/L < 1.5\nMERCURY ICP-MS 1.35 µg/L < 5\nLEAD ICP-MS 15.68 µg/L < 150\nCHROMIUM ICP-MS 9.5 µg/L < 30\nBARIUM ICP-MS 4.61 µg/L < 30\nCOBALT ICP-MS 0.69 µg/L 0.10 - 1.50\nCAESIUM ICP-MS 3.33 µg/L < 5\nTHALLIUM ICP-MS 0.04 µg/L < 1\nURANIUM ICP-MS 0.04 µg/L < 1\nSTRONTIUM ICP-MS 22.6 µg/L 8 - 38\nANTIMONY ICP-MS 5.2 µg/L 0.10 - 18\nTIN ICP-MS 0.5 µg/L < 2\nMOLYBDENUM ICP-MS 1.65 µg/L 0.70 - 4.0\nSILVER ICP-MS 1.45 µg/L < 4\nVANADIUM ICP-MS 0.56 µg/L < 0.8\nBERYLLIUM ICP-MS 0.04 µg/L 0.10 - 0.80\nBISMUTH ICP-MS 0.24 µg/L 0.10 - 0.80\nSELENIUM ICP-MS 156.72 µg/L 60 - 340\nALUMINIUM ICP-MS 13.1 µg/L < 30\nNICKEL ICP-MS 8.11 µg/L < 15\nMANGANESE ICP-MS 10.85 µg/L 7.10 - 20\nPlease correlate with clinical conditions.\nMethod :\nICP - MASS SPECTROMETRY\nNote:Reference range has been obtained after considering 95% population as cutoff.\nSample Collected on (SCT) : 06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 14:08\nReport Released on (RRT) : 06 Mar 2025 16:15\nSample Type : EDTA Whole Blood\nLabcode : [PHONE]/PP004 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)\nBarcode : DM284847\nPage : 18 of 22\n\nPROCESSED AT :\nThyrocare,\n5CA-711, 3rd Floor,\nHRBR 2nd Block,\nHennur, Bengaluru-560043\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nPEARL OF PARADISE LOCATION SHARED 560068\nREF. BY : SELF\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nHbA1c - (HPLC)\nH.P.L.C 4.9 %\nBio. Ref. Interval. :\nBio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics\nBelow 5.7% : Normal Below 6.5% : Good Control\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\n>8% : Poor Control\nMethod : Fully Automated H.P.L.C method\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 94 mg/dL\nBio. Ref. Interval. :\n90 - 120 mg/dl : Good Control\n121 - 150 mg/dl : Fair Control\n151 - 180 mg/dl : Unsatisfactory Control\n> 180 mg/dl : Poor Control\nMethod : Derived from HBA1c values\nPlease correlate with clinical conditions.\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 14:08\nReport Released on (RRT) :06 Mar 2025 16:15\nSample Type :EDTA Whole Blood\nLabcode :[PHONE]/PP004 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)\nBarcode :DM284847\nPage : 19 of 22\n\nPROCESSED AT :\nThyrocare,\n5CA-711, 3rd Floor,\nHRBR 2nd Block,\nHennur, Bengaluru-560043\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR (F),ROUTINE\nURINE ANALYSIS\nTEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.\nHEMOGLOBIN SLS-Hemoglobin Method 15 g/dL 13.0-17.0\nHematocrit (PCV) CPH Detection 46.4 % 40.0-50.0\nTotal RBC HF & EI 5.08 X 10^6/µL 4.5-5.5\nMean Corpuscular Volume (MCV) Calculated 91.3 fL 83.0-101.0\nMean Corpuscular Hemoglobin (MCH) Calculated 29.5 pq 27.0-32.0\nMean Corp.Hemo. Conc (MCHC) Calculated 32.3 g/dL 31.5-34.5\nRed Cell Distribution Width - SD (RDW-SD) Calculated 45.4 fL 39-46\nRed Cell Distribution Width (RDW - CV) Calculated 13.5 % 11.6-14\nRED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 242.6 - *Refer Note below\nMENTZER INDEX Calculated 18 - *Refer Note below\nTOTAL LEUCOCYTE COUNT (WBC) HF & FC 5.86 X 10³ / µL 4.0 - 10.0\nDIFFERENTIAL LEUCOCYTE COUNT\nNeutrophils Percentage Flow Cytometry 61.7 % 40-80\nLymphocytes Percentage Flow Cytometry 31.4 % 20-40\nMonocytes Percentage Flow Cytometry 2.7 % 2-10\nEosinophils Percentage Flow Cytometry 3.4 % 1-6\nBasophils Percentage Flow Cytometry 0.5 % 0-2\nImmature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0-0.5\nNucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0\nABSOLUTE LEUCOCYTE COUNT\nNeutrophils - Absolute Count Calculated 3.62 X 10³ / µL 2.0-7.0\nLymphocytes - Absolute Count Calculated 1.84 X 10³ / µL 1.0-3.0\nMonocytes - Absolute Count Calculated 0.16 X 10³ / µL 0.2 - 1.0\nBasophils - Absolute Count Calculated 0.03 X 10³ / µL 0.02 - 0.1\nEosinophils - Absolute Count Calculated 0.2 X 10³ / µL 0.02 - 0.5\nImmature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0-0.3\nNucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5\nPLATELET COUNT HF & EI 196 X 10³ / µL 150-410\nMean Platelet Volume (MPV) Calculated 9.8 fL 6.5-12\nPlatelet Distribution Width (PDW) Calculated 10.8 fL 9.6-15.2\nPlatelet to Large Cell Ratio (PLCR) Calculated 23.1 % 19.7-42.4\nPlateletcrit (PCT) Calculated 0.19 % 0.19-0.39\nRemarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.\n*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta\nThalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely\nto be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\n(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) :06 Mar 2025 14:08\n:06 Mar 2025 16:15\nReport Released on (RRT)\nSample Type : EDTA Whole Blood\nLabcode : [PHONE]/PP004 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)\nBarcode : DM284847 Page : 20 of 22\n\nPROCESSED AT :\nThyrocare\n1st Floor, 889 HSR layout\nSector-7 (BDA), No 1159, Bangalore\nNAME : [REDACTED](30Y/M) HOME COLLECTION :\nREF. BY : SELF PEARL OF PARADISE LOCATION SHARED 560068\n[PHONE]\nTEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR\n(F),ROUTINE URINE ANALYSIS\nTEST NAME TECHNOLOGY VALUE UNITS\nFASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 95.95 mg/dL\nBio. Ref. Interval. :-\nAs per ADA Guideline: Fasting Plasma Glucose (FPG)\nNormal 70 to 100 mg/dl\nPrediabetes 100 mg/dl to 125 mg/dl\nDiabetes 126 mg/dl or higher\nNote :\nThe assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,\nicteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and\nreagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical\nfindings and other findings.\nPlease correlate with clinical conditions.\nMethod:- GOD-PAP METHOD\n~~ End of report ~~\nSample Collected on (SCT) :06 Mar 2025 09:57\nSample Received on (SRT) : 06 Mar 2025 10:22\nReport Released on (RRT) : 06 Mar 2025 11:44\nSample Type FLUORIDE PLASMA\n:\nDr Ishant Anand MD(Path)\nLabcode : [PHONE]/PP004\nBarcode : DM740249 Page : 21 of 22\nScan QR code to verify authenticity of reported results; active for 30 days from release time.\n\nCONDITIONS OF REPORTING\nv The reported results are for information and interpretation of the referring doctor only.\nv It is presumed that the tests performed on the specimen belong to the patient; named or identified.\nv Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same\npatient.\nv Should the results indicate an unexpected abnormality, the same should be reconfirmed.\nv Only such medical professionals who understand reporting units, reference ranges and limitations of technologies\nshould interpret results.\nv This report is not valid for medico-legal purpose.\nv Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage\nthat may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims\nof any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for\nindirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the\ntotal amount of invoice for the services provided and paid for.\nv Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc\nEXPLANATIONS\nv Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\nas \"Clients\".\nv Name - The name is as declared by the client and recored by the personnel who collected the specimen.\nv Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\nv Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\nv Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\nthe barcode (irrespective of the name).\nv SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\nthe client.\nv SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\nv SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\nv RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\nv Reference Range - Means the range of values in which 95% of the normal population would fall.\nSUGGESTIONS\nv Values out of reference range requires reconfirmation before starting any medical treatment.\nv Retesting is needed if you suspect any quality shortcomings.\nv Testing or retesting should be done in accredited laboratories.\nv For suggestions, complaints, clinical support or feedback, write to us at [EMAIL]\nor call us on 022-3090 0000\n+T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)\nPage : 22 of 22",
      "biomarkers": {
        "cholesterol": "201"
      },
      "has_content": true
    }
  ]
}